
Celularity Inc. Warrant
CELUW
CELUW: Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.
moreShow CELUW Financials
Recent trades of CELUW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CELUW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CELUW's company Twitter account
Number of mentions of CELUW in WallStreetBets Daily Discussion
Recent insights relating to CELUW
Recent picks made for CELUW stock on CNBC
ETFs with the largest estimated holdings in CELUW
Flights by private jets registered to CELUW